Windlas Biotech Limited

Web: windlasbiotech.com NSE: WINDLAS BSE: 543329 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1133 6(1%)

Near 52W High of 1152

Volume

65k as on 23, Jun

Open

1,020

High

1,032

Low

1,006

1,127

VWAP

862

52 Week High

1,152

52 Week Low

697

Viand Research Rating

Quality Score

36/100

Growth Score

39/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,344

No. of Shares

2.06

P/E

35.6

P/B

4.84

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

13.59

ROCE

Profit Growth

Listing Date

16-Aug-21

Promoter Holding

63.31%

FII Holding

2.04%

DII Holding

9.84%

Price Chart

Price Performance

1 Week3%

1 Month8%

3 Months17%

6 Months13%

1 Year13%

YTD13%

Moving Average

5 Day SMA831

10 Day SMA826

20 Day SMA822

30 Day SMA807

50 Day SMA826

61 Day SMA816

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	920	870	890	927
Resistance 2	890	866	873	894
Resistance 1	874	862	862	881
Pivot Point	844	857	844	848
Support 1	828	853	827	835
Support 2	798	849	816	802
Support 3	782	845	798	789

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	May 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 63.31%	(1.41) 63.31%	(-0.11) 61.90%	(0.01) 61.98%	(-0.41) 61.98%	(0.01) 62.34%	(-0.21) 62.34%	(0.01) 62.51%	(0.01) 62.51%	(-0.31) 62.51%	(0.01) 62.82%	(0.01) 62.82%	(0.01) 62.82%	(0.51) 62.82%	(1.61) 62.37%	(0.81) 60.75%	(0.01) 59.95%	(0.01) 59.95%	(0.01) 59.95%	(0.01) 59.95%	(0.01) 59.95%
FIIs	(1.11) 2.04%	(0.41) 0.99%	(-0.31) 0.60%	(-0.21) 0.93%	(-0.31) 1.11%	(-0.11) 1.44%	(0.01) 1.52%	(-0.51) 1.55%	(0.41) 2.00%	(0.41) 1.59%	(-0.21) 1.18%	(0.61) 1.35%	(0.01) 0.80%	(-0.51) 0.80%	(-0.11) 1.32%	(-0.71) 1.45%	(-1.01) 2.19%	(-0.21) 3.21%	(-0.41) 3.40%	(-2.51) 3.77%	(0.01) 6.24%
DIIs	(-0.41) 9.84%	(-1.61) 10.20%	(0.41) 11.80%	(0.01) 11.44%	(0.21) 11.44%	(0.31) 11.22%	(0.61) 10.89%	(0.71) 10.26%	(-0.81) 9.58%	(-1.51) 10.35%	(0.11) 11.82%	(0.21) 11.71%	(0.01) 11.52%	(-0.11) 11.53%	(-0.61) 11.61%	(1.11) 12.20%	(-1.11) 11.14%	(2.41) 12.23%	(-1.51) 9.83%	(0.61) 11.30%	(0.01) 10.75%
Public	24.80%	25.49%	25.69%	25.64%	25.48%	25.01%	25.25%	25.67%	25.91%	25.55%	24.19%	24.11%	24.85%	24.84%	24.68%	25.59%	26.71%	24.62%	26.82%	24.99%	23.06%
No. of Shareholders	44,996	46,084	44,769	45,461	45,433	45,887	46,383	46,590	45,706	45,824	51,277	61,900	68,798	75,470	79,233	82,690	86,801	88,746	92,115	99,271	108,818

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	238	233	222	210	203	195	187	175	171	162	153	145	141	120	133	120	122	118	115	111
Sales Growth % (YoY)	17.7%	19.5%	18.9%	20%	18.3%	20.2%	22.5%	21%	21.7%	35.5%	15%	20.7%	15.2%	1.8%	15.2%	8.1%	14.3%	0.3%	13.8%	8.5%
Sales Growth % (QoQ)	2.1%	5%	5.7%	3.4%	4.1%	4.3%	6.9%	2.3%	5.6%	5.9%	5.5%	2.8%	17.5%	-9.8%	10.8%	-1.6%	3.4%	2.6%	3.6%	-
Expenses	213	209	194	184	177	170	164	154	149	142	134	128	124	106	117	106	108	105	102	99
Operating Profit	25	24	29	27	26	25	23	21	22	20	19	17	16	14	16	14	14	13	13	12
OPM %	11	10	13	13	13	13	12	12	13	13	12	12	12	12	12	12	11	11	11	11
Other Income	4	5	4	5	5	4	5	4	4	3	3	3	2	2	3	3	3	2	1	1
Interest	1	1	1	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	8	8	8	7	8	7	6	6	4	3	3	3	4	3	3	3	3	3	3	3
Profit before tax	20	20	24	23	21	20	20	18	23	20	18	16	15	13	16	14	14	11	11	10
Tax %	21	25	25	24	22	23	23	26	25	24	23	26	24	28	22	28	-8	28	24	30
Net Profit	16	15	18	18	16	16	16	13	17	15	14	12	11	9	12	10	15	8	8	7
Net Profit Growth % (QoQ)	6.7%	-16.7%	-	12.5%	-	-	23.1%	-23.5%	13.3%	7.1%	16.7%	9.1%	22.2%	-25%	20%	-33.3%	87.5%	-	14.3%	-
Net Profit Growth % (YoY)	-	-6.2%	12.5%	38.5%	-5.9%	6.7%	14.3%	8.3%	54.5%	66.7%	16.7%	20%	-26.7%	12.5%	50%	42.9%	-	-	-	-
TTM Net Profit	67	67	68	66	61	62	61	59	58	52	46	44	42	46	45	41	38	23	15	0
EPS in Rs	7.58	7.12	8.45	8.43	7.77	7.45	7.49	6.45	8.17	7.26	6.75	5.8	5.38	4.26	5.59	4.5	6.79	3.81	3.81	3.67

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	904	760	631	513	466	428	329	307	352
Sales Growth %	19%	20.4%	23%	10.1%	9%	30%	7%	-12.8%	-
Expenses	799	666	553	453	414	373	295	270	313
Operating Profit	105	94	78	60	52	55	34	38	39
OPM %	12	12	12	12	11	13	10	12	11
Other Income	18	18	13	10	7	-19	2	54	4
Interest	5	4	1	1	1	1	3	5	6
Depreciation	31	28	13	12	12	13	9	11	17
Profit before tax	87	80	77	57	46	22	25	76	20
Tax %	24	24	25	25	16	28	34	16	44
Net Profit	66	61	58	43	38	16	16	64	11
Net Profit Growth %	8.2%	5.2%	34.9%	13.2%	137.5%	-	-75%	481.8%	-
EPS in Rs	31.49	29.1	27.98	20.04	17.48	24.69	25.28	99.55	20.04
Dividend Payout %	20	20	20	20	20	0	0	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	105	68	109	61	9	11	25	19	35
Cash from Investing Activity	-92	-74	-92	-14	-155	-20	-14	-7	-11
Cash from Financing Activity	-13	1	-15	-44	130	1	-5	-6	-26
Net Cash Flow	0	-5	2	3	-15	-8	5	6	-2

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	11	11	10	10	10	10	11	6	6	6	6
Reserves	570	524	495	461	440	392	384	193	203	187	119
Borrowings	35	31	33	19	4	5	7	32	29	32	57
Other Liabilities	291	249	222	257	173	122	90	65	100	73	107
Total Liabilities	907	814	760	747	626	529	491	296	338	298	290
Fixed Assets	213	217	223	188	179	109	91	96	70	64	86
CWIP	60	24	5	31	6	15	8	0	0	5	53
Investments	268	246	223	182	173	107	65	23	116	122	23
Other Assets	366	327	308	346	268	298	327	177	152	107	128
Total Assets	907	814	760	747	626	529	491	296	338	298	290

Delivery

Delivery Data: WINDLAS

#	Date	808 43% 1152	Value (Cr)	Q/T 17	Del 40	Del 15
1	4-Sep	1126	22	14	44	9
2	3-Sep	1127	47	21	37	17
3	2-Sep	1097	169	23	18	30
4	1-Sep	1008	5	11	53	2
5	31-Aug	994	8	12	50	4
6	28-Aug	999	3	12	56	2
7	27-Aug	987	3	11	48	1
8	26-Aug	978	6	16	52	3
9	25-Aug	991	8	12	50	4
10	24-Aug	992	15	16	49	8
11	21-Aug	994	17	12	40	7
12	20-Aug	988	14	13	37	5
13	19-Aug	965	42	19	34	14
14	18-Aug	918	3	11	51	2
15	17-Aug	933	6	12	50	3
16	14-Aug	949	14	20	57	8
17	13-Aug	950	26	19	32	8
18	12-Aug	895	14	17	38	6
19	11-Aug	943	219	28	12	27
20	10-Aug	840	10	18	54	5
21	7-Aug	883	5	16	52	3
22	6-Aug	874	3	15	63	2
23	5-Aug	857	3	16	63	2
24	4-Aug	862	2	10	54	1
25	3-Aug	868	1	10	64	1
26	31-Jul	858	1	13	64	1
27	30-Jul	860	3	12	53	2
28	29-Jul	859	2	12	52	1
29	28-Jul	849	1	12	65	1
30	27-Jul	858	2	7	56	1
31	24-Jul	858	3	11	54	1
32	23-Jul	861	2	9	60	1
33	22-Jul	870	3	11	52	2
34	21-Jul	880	3	11	61	2
35	20-Jul	872	5	13	49	2
36	17-Jul	844	4	9	49	2
37	16-Jul	850	9	14	51	5
38	15-Jul	840	7	26	65	5
39	14-Jul	851	4	16	57	2
40	13-Jul	852	4	19	61	2
41	10-Jul	830	3	17	67	2
42	9-Jul	826	4	17	59	2
43	8-Jul	828	5	18	47	2
44	7-Jul	854	2	18	50	1
45	6-Jul	858	4	18	51	2
46	3-Jul	872	5	18	56	3
47	2-Jul	861	5	15	61	3
48	1-Jul	861	1	9	56	1
49	30-Jun	859	5	18	64	3
50	29-Jun	859	7	16	43	3

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	2,344c	18c	0.78
03-Sep	2,325c	246c	11.80
01-Sep	2,080c	14c	0.68
31-Aug	2,094c	37c	1.79
26-Aug	2,057c	14c	0.71
25-Aug	2,043c	4c	0.20
24-Aug	2,039c	6c	0.30
21-Aug	2,033c	52c	2.60
19-Aug	1,981c	84c	4.42
18-Aug	1,897c	29c	1.52
17-Aug	1,927c	34c	1.73
14-Aug	1,960c	29c	1.51
13-Aug	1,931c	82c	4.45
12-Aug	1,849c	70c	3.66
11-Aug	1,919c	126c	7.01
10-Aug	1,793c	3c	0.18
06-Aug	1,797c	18c	1.02
05-Aug	1,778c	10c	0.56
04-Aug	1,769c	4c	0.23
31-Jul	1,773c	13c	0.70
30-Jul	1,785c	17c	0.96
29-Jul	1,768c	17c	0.97
28-Jul	1,751c	9c	0.52
27-Jul	1,760c	2c	0.12
24-Jul	1,758c	0	0

Stock Checklist

Price is above from 52 week high low average: 96%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 11 fund scheme(s) across 4 fund house(s) as of Aug26 · Total value ₹185 Cr · 0 increasing / 7 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
ICICI Prudential Mutual Fund	4	0.31%	-0.03%	102.6
Bandhan Mutual Fund	4	0.09%	+0.01%	50.8
UTI Mutual Fund	2	1.17%	-0.06%	32
ICICI Prudential Asset Management Company Limited	1	0.00%	-0.09%	0

Windlas Biotech Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements